CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(1.19%)
USD 0.01
(1.19%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.38 Million USD | -35.14% |
| 2022 | 8.3 Million USD | -64.49% |
| 2021 | 23.39 Million USD | -7.35% |
| 2020 | 25.24 Million USD | 89.63% |
| 2019 | 13.31 Million USD | 45.72% |
| 2018 | 9.13 Million USD | 115.83% |
| 2017 | 4.23 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.32 Million USD | -1.52% |
| 2024 Q1 | 4.39 Million USD | -18.4% |
| 2023 FY | 5.38 Million USD | -35.14% |
| 2023 Q2 | 6.95 Million USD | -10.69% |
| 2023 Q1 | 7.78 Million USD | -6.31% |
| 2023 Q3 | 5.1 Million USD | -26.52% |
| 2023 Q4 | 5.38 Million USD | 5.48% |
| 2022 Q3 | 8.26 Million USD | -21.82% |
| 2022 Q4 | 8.3 Million USD | 0.55% |
| 2022 Q2 | 10.56 Million USD | -43.72% |
| 2022 Q1 | 18.77 Million USD | -19.74% |
| 2022 FY | 8.3 Million USD | -64.49% |
| 2021 FY | 23.39 Million USD | -7.35% |
| 2021 Q1 | 37.4 Million USD | 48.15% |
| 2021 Q2 | 53.54 Million USD | 43.17% |
| 2021 Q3 | 27.92 Million USD | -47.84% |
| 2021 Q4 | 23.39 Million USD | -16.25% |
| 2020 Q4 | 25.24 Million USD | 530.74% |
| 2020 Q3 | 4 Million USD | -72.38% |
| 2020 Q2 | 14.49 Million USD | 100.19% |
| 2020 Q1 | 7.23 Million USD | -45.63% |
| 2020 FY | 25.24 Million USD | 89.63% |
| 2019 FY | 13.31 Million USD | 45.72% |
| 2019 Q4 | 13.31 Million USD | 91.25% |
| 2019 Q3 | 6.96 Million USD | 227.09% |
| 2019 Q2 | 2.12 Million USD | -59.1% |
| 2019 Q1 | 5.2 Million USD | -43.05% |
| 2018 Q1 | 4.3 Million USD | 1.79% |
| 2018 FY | 9.13 Million USD | 115.83% |
| 2018 Q4 | 9.13 Million USD | 94.74% |
| 2018 Q3 | 4.69 Million USD | -1.13% |
| 2018 Q2 | 4.74 Million USD | 10.12% |
| 2017 FY | 4.23 Million USD | 0.0% |
| 2017 Q2 | 4.13 Million USD | 0.0% |
| 2017 Q3 | 4.26 Million USD | 3.05% |
| 2017 Q4 | 4.23 Million USD | -0.72% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| BIMI International Medical Inc. | 30.49 Million USD | 82.335% |
| China Jo-Jo Drugstores, Inc. | 80.76 Million USD | 93.33% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 241.75 Million USD | 97.772% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 241.75 Million USD | 97.772% |
| Leafly Holdings, Inc. | 34.29 Million USD | 84.291% |
| Leafly Holdings, Inc. | 34.29 Million USD | 84.291% |
| LifeMD, Inc. | 52.91 Million USD | 89.819% |
| LifeMD, Inc. | 52.91 Million USD | 89.819% |
| TRxADE HEALTH, Inc. | 11.99 Million USD | 55.071% |
| PetMed Express, Inc. | 78.36 Million USD | 93.125% |
| Walgreens Boots Alliance, Inc. | 68.85 Billion USD | 99.992% |